Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $15,550 | 3 | 55.6% |
| Unspecified | $10,573 | 6 | 37.8% |
| Travel and Lodging | $1,725 | 6 | 6.2% |
| Food and Beverage | $100.94 | 7 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $14,826 | 15 | $0 (2018) |
| Chiesi USA, Inc. | $10,573 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $2,550 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $2,550 | 1 | Merck Sharp & Dohme Corporation ($2,550) |
| 2019 | $10,573 | 6 | Chiesi USA, Inc. ($10,573) |
| 2018 | $14,826 | 15 | GlaxoSmithKline, LLC. ($14,826) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| 04/09/2019 | Chiesi USA, Inc. | — | — | Cash or cash equivalent | $232.16 | Research |
| Study: DPM-CF-303 | ||||||
| 04/04/2019 | Chiesi USA, Inc. | — | — | Cash or cash equivalent | $4,400.00 | Research |
| Study: DPM-CF-303 | ||||||
| 04/04/2019 | Chiesi USA, Inc. | — | — | Cash or cash equivalent | $3,300.00 | Research |
| Study: DPM-CF-303 | ||||||
| 04/04/2019 | Chiesi USA, Inc. | — | — | Cash or cash equivalent | $1,500.00 | Research |
| Study: DPM-CF-303 | ||||||
| 04/04/2019 | Chiesi USA, Inc. | — | — | Cash or cash equivalent | $1,058.00 | Research |
| Study: DPM-CF-303 | ||||||
| 03/27/2019 | Chiesi USA, Inc. | — | — | Cash or cash equivalent | $82.66 | Research |
| Study: DPM-CF-303 | ||||||
| 06/27/2018 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
| 06/11/2018 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $517.51 | General |
| 06/11/2018 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $231.03 | General |
| 06/11/2018 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $97.00 | General |
| 06/11/2018 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $22.38 | General |
| 06/11/2018 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $16.97 | General |
| 06/11/2018 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $10.41 | General |
| 06/11/2018 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $6.21 | General |
| 05/31/2018 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
| 05/01/2018 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $522.25 | General |
| 05/01/2018 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $231.03 | General |
| 05/01/2018 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $125.83 | General |
| 05/01/2018 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $18.70 | General |
| 05/01/2018 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $14.53 | General |
| 05/01/2018 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $11.74 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| DPM-CF-303 | Chiesi USA, Inc. | $10,573 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 21 | $14,598 | $3,687 |
| 2020 | 1 | 20 | 34 | $22,652 | $5,877 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 11 | 21 | $14,598 | $3,687 | 25.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 20 | 34 | $22,652 | $5,877 | 25.9% |
About Dr. David Jacoby, MD
Dr. David Jacoby, MD is a Critical Care Medicine healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982701751.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Jacoby, MD has received a total of $27,948 in payments from pharmaceutical and medical device companies, with $2,550 received in 2021. These payments were reported across 22 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($15,550).
As a Medicare-enrolled provider, Jacoby has provided services to 31 Medicare beneficiaries, totaling 55 services with total Medicare billing of $9,564. Data is available for 2 years (2020–2022), covering 2 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Portland, OR
- Active Since 09/20/2006
- Last Updated 09/11/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1982701751
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Portland
David Hotchkin, Md, MD
Critical Care Medicine — Payments: $57,119
Gopal Allada, Md, MD
Critical Care Medicine — Payments: $37,391
Dr. Ralph Juarez, M.d, M.D
Critical Care Medicine — Payments: $32,116
Dr. Heidi Deblock, M.d, M.D
Critical Care Medicine — Payments: $28,066
Mark Chesnutt, Md, MD
Critical Care Medicine — Payments: $15,088
Andrea Orfanakis, Md, MD
Critical Care Medicine — Payments: $9,181